ArticleBiomedicines2026
The Poly-Arginine Peptide R18D Inhibits Amyloid-Beta (Aβ) Aggregation and Aβ-Induced Cytotoxicity, Reduces Intracellular Tau Aggregation, and Exhibits Oral Bioavailability.
Vaishali Bagda, Zainab H Farooz, Neville W Knuckey, Samantha M South, Stuart K Gribble, Maitri Tomar, Prashant Bharadwaj, Ajish Ariyath, Kevin Taddei, Ralph N Martins and 1 more
Abstract read
In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Vaishali BagdaPerron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.ORCID 0009-0004-6222-7785 Zainab H FaroozPerron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.
Neville W KnuckeyPerron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.
Samantha M SouthArgenica Therapeutics, Nedlands, WA 6009, Australia.
Stuart K GribbleArgenica Therapeutics, Nedlands, WA 6009, Australia.
Maitri TomarPerron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.ORCID 0000-0003-4766-2768 Prashant BharadwajCentre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.
Ajish AriyathCentre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.
Kevin TaddeiCentre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.ORCID 0000-0002-8106-7957 Ralph N MartinsCentre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA 6027, Australia.ORCID 0000-0002-4828-9363 Bruno P MeloniPerron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.ORCID 0000-0003-0964-0648 Funding
Argenica Therapeutics N/APerron Institute for Neurological and Translational Science N/A
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Alzheimer’s diseaseamyloid-betacationic arginine-rich peptidesMC65 cellsprimary cortical neuronsR18DSH-SY5Y cellstau proteintau seeds
Identifiers
PMID42512037
PMCPMC13406487
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390